The Indications for Surgery in Acquired Heart Disease Professor J F Goodwin (RoyalPostgraduate Medical School ofLondon) Mitral Valve Disease Surgical treatment is now available for a number of acquired heart diseases. The most dramatic recent advances have perhaps come in the field of open operation for valve replacement. Table 1 lists the conditions which may now be treated surgically. It is not possible to describe all these conditions here and this discussion will be confined to aortic and mitral valve disease. I shall open by discussing the medical aspects of mitral valve disease.
The Natural History ofMitral Valve Disease
The increasing scope of cardiac surgery emphasizes the responsibility of the physician to analyse and document the natural history of heart disease, so that the place of surgical treatment can be fully evaluated. The course of patients with mitral stenosis on medical treatment was analysed by Olesen (1962) , who showed that the survival after twenty years of observation was under 20 %, a figure which contrasts sharply with the survival rate in the normal population. While many patients have mixed mitral stenosis and regurgitation, the natural history differs between those with pure stenosis and those with free or dominant regurgitation. The latter lesion usually reflects a degree of rheumatic carditis involving the mitral valve much more severel than in pure stenosis. In pure mitral stenosis there is commonly a period of several years without symptoms and often no history of rheumatic fever, symptoms then beginning gradually with dyspnoea, tiredness, bronchitis in the winter and hmmoptysis. Fig 1 shows the natural history of mitral valve disease and the hazards to which patients are exposed. The course tends to be a gradually downhill one, punctuated by various crises, such as deterioration in pregnancy, often with considerable improvement afterwards. Atrialfibrillation, which occurs in the majority of patients with significant mitral stenosis in middle age, often produces deterioration in effort tolerance, sometimes severely at the onset, but less so when the ventricular rate has been brought under control by treatment. Once atrial fibrillation has started the patient is at risk from systemic embolism, which is a most serious and often catastrophic hazard.
The frequency of systemic embolism in mitral valve disease is distressingly high, and may be directly related to the size of the left atrial appendage (Somerville & Chambers 1964) . In Bannister's (1960) study, embolism occurred in 22 of 105 patients followed for an average of 4 5 years. At the Royal Postgraduate Medical School over a ten-year period the incidence of probable or certain systemic embolism was 40-45 % of 155 patients with atrial fibrillation and 16 patients had more than one embolism. The incidence was equal in those with pure stenosis and in those with mixed lesions. Apart from the obvious hazards of cerebral, peripheral or visceral embolism, it is probable that occult renal emboli may be a cause of systemic hypertension. In a study by my colleagues, Obeyesekere et al. (1965) , there was a close relation between atrial fibrillation, systemic hypertension and renal infarction seen at necropsy.
Patients with pure mitral stenosis are not greatly at risk from bacterial endocarditis but If no surgical treatment is available, the disease progresses to tricuspid regurgitation, pulmonary embolism and finally death. The whole process takes perhaps twenty or thirty years unless life is suddenly terminated by embolism or (in the minority of cases) by pulmonary oedema.
In pure or dominant mitral stenosis pulmonary edema is not common except in pregnancy or as a result of some intercurrent complication such as rapid atrial fibrillation, chest infection, bacterial endocarditis, or extreme effort.
The persistent elevation of left atrial pressure produces chronic pulmonary venous hypertension, which is accompanied in the majority of patients by modest pulmonary arterial hypertension and in the minority by severe reactive pulmonary arteriolar vasoconstriction and gross pulmonary arterial hypertension. The increased pulmonary venous pressure is responsible for the dyspnoea, bronchitis and hmmoptysis. It is very unusual, however, for pulmonary vascular disease in mitral stenosis to progress rapidly to a serious, irreversible or fatal outcome and it can be partially reversed by surgical treatment (Werko 1964) . If the left atrial pressure can be restored to normal, as after successful mitral valve replace- (Braunwald et al. 1965) . Regular observation serves to detect a rising pulmonary vascular resistance. Mitral stenosis is for many years an incapacitating rather than a mortal disease, but for the hazards of systemic embolism, infective endocarditis and pulmonary oedema in pregnancy. Active carditis can occur in adult life in patients with established rheumatic heart disease and may contribute to a fatal outcome (Wee & Goodwin 1966) Long-term antistreptococcal prophylaxis is therefore advisable.
In mitral regurgitation the symptoms tend, in severe cases, to come on within a relatively short interval after the acute attack of rheumatic fever and it is common for patients with severe rheumatic mitral regurgitation to have a history of multiple severe attacks of rheumatic carditis. Many patients, however, remain symptomless for long periods, and despite considerable cardiac enlargement may be relatively free from dyspnoea ( Fig 2) . The development of dyspnoea depends upon the elevation of the left atrial pressure and this in turn depends upon the compliance of the left atrium. If the left atrium is very large and compliant, the pressure may not rise greatly and pulmonary venous hypertension may be mild or (Braunwald & Awe 1963) . In other patients with a smaller, tighter left atrium, dyspncea may be more marked because of an increase in pulmonary venous pressure.
The onset of atrialfibrillation is governed both by the damage to the left atrium by the rheumatic process, and by the size of the chamber. Very large left atria nearly always fibrillate. The onset of atrial fibrillation in mitral regurgitation commonly causes considerable deterioration.
Patients with modest mitral regurgitation are far more at risk from bacterial endocarditis than those with pure stenosis and this may cause disastrous deterioration. Systemic embolism is less common in pure regurgitation than in pure stenosis, but in patients with mixed forms of the disease, embolism is equally common, and mitral regurgitation does not confer any protection against embolism. Systemic embolism usually occurs in patients with established atrial fibrillation, but can also occur during paroxysms of atrial fibrillation with subsequent return to sinus rhythm. Emboli are often dislodged by the onset of established fibrillation. However, the occurrence of systemic embolism in sinus rhythm should always raise the suspicion of bacterial endocarditis or of a left atrial myxoma (Goodwin 1963) .
Indicationsfor Mitral Valvotomy
The mere presence of mitral stenosis is not of itself a sufficient indication for surgery. But when severe symptoms are present or embolism threatens, then surgery is required. Progressive exertional dyspnoea, winter bronchitis and hemoptysis indicate a significantly elevated left atrial pressure and constitute an appreciable and tedious burden for the patient to bear. The onset of atrial fibrillation indicates that the patient is at risk from systemic embolism of which there is commonly no warning.
Before deciding upon mitral valvotomy, it is essential that objective evidence of critical mitral stenosis must be present. Thus a loud first heart sound at the apex, a full length mitral diastolic murmur and early opening snap are important features. The loud first sound and opening snap usually, though not always, indicate a mobile valve which should respond well to valvotomy. A systolic murmur indicates rigidity or some regurgitation. Signs of pulmonary hypertension are commonly not severe and are not an essential indication for operation.
Radiological evidence of pulmonary vascular changes with enlargement of the vessels in the upper zones and narrowing in the lower zones with interstitial cedema shown by horizontal costophrenic lines all confirm the presence of a high pulmonary venous pressure (Fig 3) . In pure or dominant mitral stenosis unaccompanied by other valve lesions, the heart does not usually enlarge greatly and the presence of considerable cardiomegaly is a warning that some other lesion may be present or that mitral regurgitation may be associated. Fluoroscopy or tomography to detect the heavily calcified valve, which responds poorly to simple valvotomy, are important.
Electrocardiographic evidence of considerable left atrial enlargement and right ventricular hypertrophy indicates marked pulmonary vascular disease and suggests that the mitral valve disease is severe but does not guarantee pure stenosis.
It is important first to establish whether the patient has critical mitral stenosis without regurgitation and second to determine whether the symptoms warrant operation. Patients are often seen who have the signs of critical stenosis, yet are remarkably free from symptoms. Unless atrial fibrillation and the risk of embolism are present there is no immediate necessity for valvotomy. The risk of mitral re-stenosis suggests that operation should not usually be done prophylactically.
When atrial fibrillation develops and the patient is at risk from embolism, the indications for operation become more urgent. If the valve is suitable for valvotomy, the operation should be carried out under anticoagulant cover. The enlargement in valve orifice and the obliteration of the left atrial appendage (which often harbours thrombus) both reduce the risk of embolism. The use of anticoagulant cover before or during and after mitral valvotomy virtually abolishes the risk of operative or immediate post-operative systemic embolism (Smith et al. 1965) . The correct policy for a patient with critical mitral stenosis who develops atrial fibrillation is to start anticoagulant treatment, perform valvotomy four to six weeks after anticoagulants have been started, and to continue the anticoagulants four to six weeks after operation. In patients who have recently (within six months), developed atrial fibrillation, conversion by DC countershock will produce sinus rhythm in the majority, which is maintained in most. Thus the two main causes of embolism will have been removed, notably obstruction to the mitral valve and atrial fibrillation.
Ideally, all patients approaching the age of 40, when atrial fibrillation is likely to develop, should be put on long-term anticoagulants, but current drugs do not justify this policy.
Thus the main indications for operation are relief of symptoms of pulmonary congestion and prevention of embolism.
Hemodynamic proof of mitral obstruction is not necessary before valvotomy is advised in the majority of cases, but when doubt exists as to the severity of the symptoms or the symptoms do not match the physical signs then measurement of the mitral gradient is desirable by the transseptal technique of cardiac catheterization or by measurement of the pulmonary venous wedge pressure. Characteristically, the left atrial or indirect left atrial pressure pulse shows a slow 'y' descent due to obstruction at the mitral valve as opposed to mitral regurgitation, where there is a rapid 'y' descent and a period of diastasis. Left ventricular cine-angiocardiography is advisable if there is doubt as to the amount of mitral regurgitation.
Mitral Valvotomy in Pregnancy
Mitral valvotomy in pregnancy is remarkably well tolerated by both mother and feetus and if the indications are present there should be no hesitation in advising the operation. Many patients with moderate stenosis become significantly symptomatic as a result of the extra circulatory burden imposed by pregnancy but those with critical stenosis who may have only few symptoms before pregnancy may be in danger of acute pulmonary cedema, which may come on suddenly after exertion, especially in the patient who is not aware of the valve lesion and has not been restricting physical activity. In many patients bed rest, salt restriction, digitalis, and diuretics when indicated, will be sufficient to tide them over the pregnancy, but some will continue to have persistent dyspnoea, despite rest and full medical treatment. If dyspncea is accompanied by hemoptysis and by persistent tachycardia or persistent rales at the bases of the lungs then mitral valvotomy becomes urgently indicated. In these patients clinical evidence of tight stenosis with a full-length diastolic murmur is particularly valuable in indicating the severity of the stenosis.
Contraindications to Mitral Valvotomy
The two absolute contraindications are lack of severity of stenosis on the one hand and the presence of an unsuitable valve by virtue of extreme rigidity, heavy calcification or considerable regurgitation on the other. Rigid and heavily calcified valves always leak. Adverse factors which do not necessarily contraindicate operation consist of a rigid valve with some calcification; calcification in the left atrium which may make access to the valve difficult ( Fig  4) ; the presence of a systolic murmur due to some mitral regurgitation; and an unduly large heart suggesting myocardial disease or the presence of other valve lesions. Finally, patients over the age Fig 4 Lateral chest radiograph with barium in the esophagus showing heavily calcified left atrium of 50 years tend to have more complications, a more stormy post-operative period and a less than optimal result, possibly due to atherosclerotic disease in the coronary arteries or elsewhere and to myocardial factors which are not yet fully understood. Furthermore, in older patients the state of the valve may be more difficult to diagnose clinically and in our experience regurgitation may occasionally be silent or appear slight when in fact it is severe. Rigidity in a valve with a relatively large orifice and incompetence may cause considerable obstruction, the signs of which dominate the auscultatory findings although the valve is quite unsuitable for valvotomy.
Indications for Mitral Valve Repair or Replacement
Mitral valve repair or replacement is required for mainly regurgitant or heavily calcified valves. These operations are far more extensive than mitral valvotomy, since they need cardiopulmonary bypass in order to operate inside the heart. Thus the symptoms and signs must be more demanding for open operation than for valvotomy especially as the ideal mitral prosthesis has yet to be developed.
Therefore mitral valve replacement should be restricted to patients with serious progressive and incapacitating symptoms due to mitral regurgitation despite medical treatment (Barnard & Schrire 1961) . For patients with moderately severe symptoms who are not deteriorating and who may expect a number of years of life ahead without the immediate prospect of incapacity, surgery should be postponed until the operation becomes more satisfactory. Nevertheless there are many for whom open operation becomes essential because of severe symptoms, deterioration, and heart failure. Such patients with a calcified and rigid valve producing considerable mitral stenosis and incompetence, accompanied by pulmonary vascular disease and serious symptoms, need mitral valve replacement, for valvotomy will not achieve a satisfactory result and repair is not feasible. Some patients who have severe mitral regurgitation and are unsuitable for valvotomy may sometimes be helped by mitral valve repair, particularly if the anterior cusp of the mitral valve is mobile, as shown by an accentuated first heart sound and opening snap (Wooler et al. 1962 , Logan et al. 1967 .
In additon to the symptomatic indications for open mitral valve surgery, it is essential that the diagnosis should be correct. The signs of mitral regurgitation are well known. The pulse is often small and somewhat sharp, the left ventricle is moderately enlarged, with an ill-sustained thrust.
There is a pan-systolic murmur at the apex radiating into the axilla. In free regurgitation there is a third heart sound of low intensity heard at the apex and not radiating widely, followed by a short decrescendo diastolic murmur. A mid-diastolic murmur is always present in mitral regurgitation and is due to the increased volume of blood from the left atrium passing rapidly through the valve orifice. The decrescendo nature of the diastolic murmur is an important sign in excluding severe obstruction. An opening snap is not infrequently present in severe mitral regurgitation if there is some mobility. While the length of the diastolic murmur is important in gauging severity in pure mitral stenosis, it is much less valuable when regurgitation and stenosis are associated, and patients with dominant mitral regurgitation may have a full-length mitral diastolic murmur. Atrial fibrillation is very commonly present in patients with severe mitral reguigitation of rheumatic origin. Its absence in a patient with severe symptomatic mitral regurgitation suggests that the lesion may not be rheumatic. The left atrium is usually substantially enlarged and this may be evident clinically by the lifting pulsation of the sternum which is often erroneously attributed to the right ventricle. There may also be pulsation and dullness to the right of the sternum. Patients with mitral regurgitation frequently do not have the degree of pulmonary hypertension sometimes seen in mitral stenosis but they tend to develop tricuspid regurgitation which is due either to associated rheumatic involvement of the tricuspid valve or to pulmonary vascular disease. Tricuspid regurgitation may be accompanied by congestive heart failure, which is relatively common in severe mitral regurgitation and relatively unusual in pure mitral stenosis except late in the disease. The heart in mitral regurgitation is much larger than in pure mitral stenosis, usually because of considerable enlargement of the left, and sometimes of the right atrium.
The electrocardiogram in mitral regurgitation tends to show some evidence of left ventricular hypertrophy, but in many cases the ventricular balance remains normal due to enlargement of both ventricles.
Cardiac catheterization is useful in deciding whether tricuspid incompetence is the result of pulmonary hypertension or of associated rheumatic disease. When tricuspid regurgitation is the result of pulmonary vascular disease effective reduction of the left atrial pressure by mitral valve surgery will-reduce the pulmonary arterial hypertension and relieve the tricuspid incompetence, thus obviating the need for any operation on the tricuspid valve (Braunwald et a!. 1967 ).
The left atrial pressure pulse in severe mitral regurgitation shows a tall 'v' wave and rapid 'y' descent and usually a small diastolic gradient between the left atrium and the left ventricle. The left atrial pressure may be normal in patients with a very large or compliant left atrium, explaining why little dyspncea may be present with considerable cardiomegaly (Braunwald & Awe 1963) .
Left ventricular cine-angiocardiography quantitates the degree of mitral regurgitation.
An important differential diagnosis of mitral regurgitation is tricuspid regurgitation occurring as a result of severe pulmonary hypertension in mitral stenosis. The right ventricle may be very large and the pansystolic murmur of tricuspid regurgitation may be heard to the left of the sternum in the area usually occupied by the cardiac apex, thus simulating mitral regurgitation.
Contraindications to Mitral Valve Repair or Replacement
At the present time these consist almost entirely of insufficient severity and absence of features indicating the likelihood of deterioration to complete incapacity or death. Patients should be carefully watched, since postponement for too long can lead to irreversible myocardial damage. Relative contraindications consist of prolonged congestive heart failure with long periods of diuretic therapy, hypokalhmia, chronic liver damage in the form of cardiac cirrhosis, impaired renal function, systemic hypertension and the presence of other significant valve lesions. Chronic lung disease in the form of airways obstruction, and pulmonary insufficiency greatly add to the risks of the operation and the hazards of the post-operative period.
Even unimpressive aortic regurgitation may sometimes make mitral valve replacement extremely difficult and necessitate attention to the aortic valve as well as to the mitral. But multiple valve replacement is practicable, and preferable to leaving a patient with severe aortic and tricuspid lesions which prejudice recovery from mitral replacement.
Few patients should be summarily rejected for surgery on the grounds that the condition is too severe. The most suitable patient is one who has serious and demanding symptoms but who has not been in heart failure for a long period, who has not had a long period of diuretic therapy, whose hepatic and renal function is satisfactory and whose other valves are intact.
Additional Valve Lesions
Mild or even moderate aortic regurgitation, although sometimes tending to become more obvious after mitral valvotomy, does not usually impair a successful result. In combined aortic and mitral valve disease, it may be of great importance to be certain which of the valve lesions is mainly responsible for symptoms. Dyspnoea, hmmoptysis and atrial fibrillation, are commonly the result of mitral valve disease, whereas aortic valve disease may be symptomless, but when severe causes syncope and angina. In many cases hmmodynamic studies involving the measurement of gradient across both valves and aortography or left ventricular angiography are required in order to evaluate the degree of involvement of other valves. Aortography is important in patients with serious mitral regurgitation in whom the presence of more than slight aortic regurgitation may necessitate replacement of the aortic valve also.
Nonrheumatic Subvalvar Mitral Regurgitation, Ruptured Chord?, Papillary Muscle Insufficiency Acute subvalvar mitral regurgitation (Raftery et al. 1966 ) presents with sudden severe dyspncea or pulmonary oedema and an ejection type of systolic murmur at the apex and base (Burch et al. 1963) . It usually follows either cardiac infarction or infective endocarditis involving the mitral valve. When symptoms are not improved by medical treatment the possibility of surgery must be carefully considered, particularly in a patient who has had a cardiac infarction and remains severely breathless, or in pulmonary oedema due to the sudden severe mitral regurgitation. The heart remains relatively small in contrast to the enlargement seen in pulmonary cedema due to myocardial ischimic failure. Strikingly successful results can be obtained by valve repair or replacement in patients with acute subvalvar mitral regurgitation (Fluck et al. 1966 ).
Summary
Patients with pure mitral stenosis and progressive incapacitating symptoms should be offered mitral valvotomy, which has a high chance of success. Mitral valvotomy is also indicated in all patients with pure mitral stenosis to prevent embolism when atrial fibrillation develops and should be carried out under anticoagulant cover. In patients with recent atrial fibrillation the arrhythmia may be converted to sinus rhythm by DC countershock after operation, thus further reducing the risk of embolism. In pregnancy, mitral valvotomy is urgently indicated when symptoms of pulmonary congestion appear and pulmonary cedema threatens despite full rest in bed and medical treatment.
Mitral valvotomy should be approached with caution in the patient over the age of 50 for, although excellent results can be obtained, the degree of improvement is often less, and the mortality is higher than in younger patients.
Mitral valve replacement should be confined to patients with serious, progressive or gravely incapacitating symptoms. Patients with moderate disability of a non-progressive nature should not be operated on at the present time until the risks of embolism from prostheses have been overcome.
In acute subvalvar mitral regurgitation due to chordal rupture or papillary muscle insufficiency, early operation may be the only means of treating persistent pulmonary oedema. Surgery for aortic valvar disease has advanced considerably in the last five years, and now offers to seriously incapacitated patients, whose outlook was previously very poor, a chance for the relief of symptoms and a better life expectancy. In considering the indications for operation in these patients it is important to realize that once a diagnosis of aortic stenosis, regurgitation, or a mixed lesion has been made on an anatomical basis, it is essential to evaluate the lesion physiologically. Table 1 shows the different recognized types of aortic obstruction; the valvar lesions will be particularly considered in relation to operation.
The etiology of aortic valvar disease may be important in considering the patient for surgery; Mr Donald Ross (p 1021) considers those lesions which are suitable for homograft replacement of the aortic valve, and those which are not.
Rheumatic and congenital lesions are the commonest. The collagen disorders are increasingly recognized, also Marfan's syndrome. Syphilis has become relatively uncommon. Other Ttiological causes include bacterial endocarditis which usually occurs in an already diseased valve, atherosclerotic aortic valvar disease, which seldom, if ever, produces a physiologically critical derangement of the valve, and dissecting aneurysm. Aortic regurgitation may occur with systemic hypertension, and after trauma, and has been recognized in ochronosis (Mody 1964, personal communication) .
The itiology in 146 consecutive cases of homograft replacement of the aortic valve, that have been performed by Mr Donald Ross at the National Heart Hospital, was as follows (McDonald et al. 1967) : It was rheumatic in 85, in 5-of whom there was additional subvalvar obstruction, and congenital in 58, of whom 7 had subvalvar obstruction. Two of the congenital cases had ventricular septal defect and one a left ventricular-right atrial shunt. There was one luetic case and in 2 instances a homograft was inserted in patients in whom a Starr-Edwards valve had become infected with bacterial endocarditis. Amongst these 146 cases 24 had had past bacterial endocarditis, and in 7 there was active bacterial endocarditis at the time of operation. These patients had failed to respond to antibiotic treatment and homograft replacement was successfully performed as an elective procedure.
The symptoms of aortic valvar disease are well recognized, but recent experience (McDonald et al. 1966 ) has, to some extent, modified views on these. Symptoms should be considered with regard to the natural history of the disease. Aortic valvar disease is characterized by a prolonged asymptomatic period in which the patient may be symptom free in the presence of a severe obstructive or regurgitant lesion. Thus the onset of symptoms is usually relatively late in the disease, compared for instance with mitral stenosis, and the patient's downhill course may be comparatively rapid after symptoms commence. 
